---
document_datetime: 2025-03-06 11:33:36
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/yorvipath-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: yorvipath-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.8234202
conversion_datetime: 2025-12-19 02:44:10.673234
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Yorvipath

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| N/0008               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 27/02/2025                          |                                             | PL                               |                                   |
| PSUSA/173/2 02405    | Periodic Safety Update EU Single assessment - palopegteriparatide                                | 28/11/2024                          | n/a                                         |                                  | PRAC Recommendation - maintenance |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0007/G   | a group of variations. B.IV.1.z - Change of a measuring or administration device - Other variation B.IV.1.z - Change of a measuring or administration device - Other variation B.IV.1.b - Change of a measuring or administration device - Deletion of a device B.IV.1.b - Change of a measuring or administration device                   | 12/11/2024   |     | SmPC, Labelling and PL   | This was an application for device - Deletion of a   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-----|--------------------------|------------------------------------------------------|
| IB/0005     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                              | 26/07/2024   |     | SmPC and PL              |                                                      |
| IAIN/0004   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                          | 11/04/2024   | n/a |                          |                                                      |
| IB/0002     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                              | 09/04/2024   |     | SmPC                     |                                                      |
| IB/0003/G   | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change protocol | 08/04/2024   | n/a |                          | to an approved stability                             |

<div style=\"page-break-after: always\"></div>

| IB/0001   | B.I.d.z - Stability of AS - Other variation   | 25/03/2024   | n/a   |
|-----------|-----------------------------------------------|--------------|-------|